April 4, 2008 - St. Jude Medical placed at center stage at ACC the company’s Promote RF CRT-D and Current ICD, combined with the new Durata lead, and the QuickOpt Timing Cycle Optimization.
The Promote RF CRT-D and Current RF ICD, which feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.
The Durata defibrillation lead is the first St. Jude Medical lead with an innovative soft lead tip and slightly curved RV coil, designed to optimize the lead tip-endocardium interface.
Representing the latest advancements in lead technology, the Durata lead features exclusive technologies designed for long-term reliability, more control during implantation, and options to accommodate varying patient needs and physician preferences - all while being the thinnest of any competitive lead on the market.
QuickOpt Timing Cycle Optimization was another tool on display, offering alternative to time-consuming echocardiography procedures. By programming appropriate AV and VV delays (timing cycle optimization), research has shown to be effective at improving patient outcomes by increasing cardiac output and reducing non-responder rates.